Page last updated: 2024-08-23

nedocromil and Left Ventricular Dysfunction

nedocromil has been researched along with Left Ventricular Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Janicki, JS; Jubair, S; Li, J	1

Other Studies

1 other study(ies) available for nedocromil and Left Ventricular Dysfunction

Article	Year
Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:2 Topics: Animals; Cardiomyopathy, Hypertrophic; Cell Degranulation; Cell Size; Chymases; Collagen; Estradiol; Estrogen Replacement Therapy; Female; Hypertrophy, Left Ventricular; Mast Cells; Myocardium; Myocytes, Cardiac; Nedocromil; Oligopeptides; Organ Size; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling	2015

Article

Year

Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:2

Topics: Animals; Cardiomyopathy, Hypertrophic; Cell Degranulation; Cell Size; Chymases; Collagen; Estradiol; Estrogen Replacement Therapy; Female; Hypertrophy, Left Ventricular; Mast Cells; Myocardium; Myocytes, Cardiac; Nedocromil; Oligopeptides; Organ Size; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling

2015